Guardant Health (GH) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order by the Co-CEO and Chairperson, conducted virtually to maximize accessibility for stockholders.

• Rules of conduct and agenda were made available on the web portal, with procedures for voting and asking questions clearly outlined.

• Only stockholders of record as of April 15, 2024, were eligible to participate and vote.

Board and executive committee updates

• The Board of Directors and key executives, including the Co-CEOs and other board members, were present.

• Representatives from Deloitte & Touche LLP (auditors) and Gunderson Dettmer (legal counsel) also attended.

Overview of voting outcomes

• A quorum was established with proxies for over 97 million shares, representing 79.7% of outstanding shares.

• All three Class 3 director nominees were elected by plurality vote.

• Ratification of Deloitte & Touche LLP as independent auditors for 2024 was approved by majority vote.

• Advisory approval of executive compensation received a majority of votes cast.

• Final voting results will be filed with the SEC on Form 8-K within four days.